FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileCanton Strategic Holdings Inc
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
CNTN
Canton Strategic Holdings Inc Stock AnalysisComprehensive stock analysis for Canton Strategic Holdings Inc (CNTN) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisCNTN
CNTN
Canton Strategic Holdings Inc
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
CNTN
  1. Home
  2. Stocks
  3. Canton Strategic Holdings Inc

Canton Strategic Holdings Inc

🇺🇸CNTN•NASDAQ

Canton Strategic Holdings Inc

🇺🇸CNTN•NASDAQ
Market cap
$98.78M

Your view on CNTN

Mkt Cap
$98.78M
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Canton Strategic Holdings Inc

Industry
Biotechnology
Sector
Healthcare
CEO
Mark Wendland
Headquarters
34 Shrewsbury Avenue, Red Bank, NJ, US
Industry
Biotechnology
Sector
Healthcare
CEO
Mark Wendland
Headquarters
34 Shrewsbury Avenue, Red Bank, NJ, US
Description

Canton Strategic Holdings Inc., which was formerly known as Tharimmune, Inc. until its name change in February 2026, focuses on two primary areas.

The company is committed to promoting the institutional integration of blockchain technology and fostering the digitization of financial markets, primarily by leveraging Canton Coin and offering support to the Canton network. In addition to its blockchain initiatives, the company is also deeply involved in pharmaceutical research and development.

Its pipeline includes GV104, a buccal film technology designed to address respiratory and/or nervous system depression in military personnel and chemical incident responders, which has already finished its Phase 1 trial.

Another significant project is GV023, an oral version of infliximab, engineered to resolve the key inconvenience of the standard intravenous treatment by eliminating the need for recurring infusions. Established in 2017, Canton Strategic Holdings Inc. is headquartered in Red Bank, New Jersey.

Financial Data

Stock Data

Price chart, volume, and trading data.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Canton Strategic Holdings Inc. Starting points for Canton Strategic Holdings Inc: EPS -$0.60, beta 1.51 — an Biotechnology name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Canton Strategic Holdings Inc. Trailing twelve-month EPS for Canton Strategic Holdings Inc stands at -$0.60. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Canton Strategic Holdings Inc. Canton Strategic Holdings Inc has reported as a listed company since 2022. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold CNTN12 companies
More Biotechnology companies
TickerTypeCompanySectorExchangeMkt cap
QTTBQ32 Bio Inc.HealthcareNASDAQ$249.6M
QUREuniQure N.V.HealthcareNASDAQ$1.4B
RAC.AXRace Oncology LimitedHealthcareASX—
RAD.AXRadiopharm Theranostics LimitedHealthcareASX—
RADXRadiopharm Theranostics LimitedHealthcareNASDAQ$812,081
RANIRani Therapeutics Holdings, Inc.HealthcareNASDAQ$33.4M
RAPPRapport Therapeutics, Inc. Common StockHealthcareNASDAQ$1.1B
RAREUltragenyx Pharmaceutical Inc.HealthcareNASDAQ$1.7B
RASPActavia Life Sciences, Inc.HealthcareOTC$385,906
RBSHRebus Holdings, Inc.HealthcareOTC$3,213
RCARRenovaCare, Inc.HealthcareOTC$8,735
RCE.AXRecce Pharmaceuticals LtdHealthcareASX—
Ownership & News

Institutional Ownership

Which funds and firms own the stock.

About this section

Which institutions hold Canton Strategic Holdings Inc, and how their positions are changing. At a $98.8M market value, institutional positions materially move Canton Strategic Holdings Inc's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.

Insider Trading

Recent buying and selling by company executives.

About this section

Buying and selling by Canton Strategic Holdings Inc executives and directors. Shares of Canton Strategic Holdings Inc have traded between $1.08 and $9.08 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for Canton Strategic Holdings Inc. Coverage tracks Canton Strategic Holdings Inc within Biotechnology (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Canton Strategic Holdings Inc.

CNTN AnalysisFair
Past
1
Growth
2
Health
5
Profit
1
Value
1